Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Oct 13, 2017 (9 years ago)

Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Superpotent drug: out of specification result for potency

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40

Affected NDC 61553-0352-40

Compare with the code on your package — it is the most precise check available.

Drug: Hydromorphone

Recalling firm
PharMEDium Services, LLC.
NDC code
61553-352-40
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0080-2018 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Hydromorphone recalls

See all

Other recalls by PharMEDium Services, LLC.

All 2017 recalls